METHOD FOR TREATING PSORIASIS Russian patent published in 2008 - IPC A61K38/08 A61P17/06 

FIELD: medicine, dermatology.

SUBSTANCE: complex medicinal therapy should be supplemented with endonasal usage of deltaran per 0.3 mg twice daily at the stage of process progressing at course dosage being 6-8.4 mg for 10-14 d. At the stage of remission one should apply deltaran as monotherapy under conditions of stress situations per 0.3 mg once daily and for preventive purposes in the period of the most probable seasonal exacerbation per 0.3 mg nocturnally at course dosage ranged 3-6 mg for the period of 10-20 d.

EFFECT: higher efficiency of therapy.

3 ex